Categories
Politics

In Louisiana, Public Well being Employees Fight Vaccine Misinformation

Mayor Adrian Perkins, a Shreveport native and graduate of West Point and Harvard Law School who served in the Iraq and Afghanistan wars, was sued last year when he tried one. On Friday, he announced a new advisory urging residents to wear masks indoors, a day after the parish commission voted to postpone action on a mandate.

The falsehoods filling social media feeds dwarf whatever vaccine salesmanship power he has, he said. One complicating phenomenon, he said, was the sharing of misinformation between the Black community, which has a long-held skepticism of vaccines, and a white population that sees the vaccine and virus restrictions as government overreach.

Dr. Whyte framed her struggles getting people vaccinated as part of a broader negligence of public health. She said her department was continually underfunded despite significant rates of syphilis and maternal and infant mortality. It is wrestling with infant vaccinations and the spread of sexually transmitted diseases, and is fighting an increase in drug overdoses.

Her department has 99 employees, but few for preventing and tracking infectious disease. She oversees one epidemiologist and a community health worker supervisor who has no one to supervise. She is starting to see some help from federal funding appropriated during the pandemic: She plans to hire three community health workers soon, a social worker to replace one who retired years ago, and at least one more epidemiologist, most likely with funds provided by the C.D.C. She manages contact tracing with a small team.

As Dr. Whyte explained the city’s challenges in an interview, Calandre Singh, an epidemiologist in Shreveport for the state health department, interrupted with a warning. The funeral for a police deputy in neighboring Webster Parish was set for the next day and was likely to draw hundreds of people indoors, likely without masks — a possible superspreading event. Dr. Whyte and her team consulted with the organizers, who promised to enforce social distancing and a mask requirement. No outbreak has been tied to the event thus far, she said.

Within a month, Dr. Whyte anticipates even knottier debates about the need for masks and vaccines in schools. Federal regulators have not yet authorized the vaccine for the youngest children, but those 12 to 15 have been eligible for the Pfizer-BioNTech vaccine since May.

At times over the last year, Dr. Whyte has felt so emotionally wrung out that she has been tempted to quit. Her otherwise healthy husband, a physician, spent two months on a ventilator last year, an experience she describes vividly in her pitches to community members about vaccination. The exchange with Ms. Peavy at the City Council meeting had left her angry and depleted.

Categories
World News

High shareholder Data Edge on the preliminary public providing

A Zomato Delivery boy adjusts a grocery order in his delivery bike amid the Covid-19 (Coronavirus) pandemic on November 8, 2020 in New Delhi, India.

Nasir Kachroo | NurPhoto | Getty Images

Indian internet company Info Edge has no plans to sell its entire stake in Zomato if the grocery delivery startup goes public, a senior executive said.

Zomato filed for an initial public offering of up to Rs. 82.5 billion ($ 1.1 billion) in April, in which the company will issue new shares valued at up to Rs. 75 billion. The company plans to use the proceeds to fund organic and inorganic growth initiatives, which may include mergers or acquisitions.

Info Edge, the startup’s largest shareholder, will sell shares valued at up to 7.5 billion rupees ($ 101 million), the company said in an IPO in April.

“We continue to invest in Zomato, we will not sell our entire stake,” said Chintan Thakkar, CFO and Executive Director at Info Edge, told CNBC’s Street Signs Asia on Tuesday.

Zomato participants

Info Edge was the first institutional investor to support Zomato and, according to Thakkar, currently holds around 17% of the shares in the start-up. Other shareholders include rideshare giant Uber, Alibaba subsidiary Ant Group and Singapore state investor Temasek.

“What we announced is that we could hit up to $ 100 million,” he said, referring to the number of Zomato shares Info Edge could sell. “We still have the option of not paying even $ 100 million.”

“Most of our stake will likely stay in Zomato, so we will keep investing in it,” said Thakkar.

Thakkar didn’t want to reveal when Zomato’s IPO could take place.

He said anything Info Edge receives from the offering will be added to existing funds that are likely to be used in the company’s operations and can be used to buy or acquire a strategic minority stake in potential midsize companies.

Info Edge will primarily deal with technology startups or “anything that has a sizeable market and can disrupt the existing market,” he added.

India’s fragmented food delivery scene

Together with rival start-up Swiggy, Zomato dominates the US $ 4.2 billion grocery delivery market in India, which is highly competitive but also very fragmented.

In its prospectus, Zomato said it faces intense competition from chain restaurants that have their own online ordering platforms. Other competitors are cloud kitchens and restaurants that operate their own delivery fleets, as well as offline orders over the phone.

The company also said the pandemic had a significant impact on business last year as most restaurants were temporarily closed and many customers were unwilling to order outside food. Zomato said its restaurant service income was also severely impacted.

In February, Zomato said it raised $ 250 million from donors like Tiger Global Management and Fidelity. That was months after a $ 660 million financing round closed.

Categories
World News

Virgin Orbit in talks with SPAC for $three billion deal to go public

Richard Branson’s Virgin Orbit takes off on a rocket under the wings of a modified Boeing 747 jetliner for a major drop test of its high-altitude launch system for satellites from Mojave, Calif., July 10, 2019.

Mike Blake | Reuters

Virgin Orbit, the satellite launch spin-off from Sir Richard Branson’s Virgin Galactic, is in advanced discussions to go public via a SPAC led by a former Goldman Sachs partner valued at approximately $ 3 billion , confirmed CNBC on Saturday.

The company is in talks about a deal with NextGen Acquisition II, a person familiar with the discussions told CNBC. NextGen II is a special-purpose acquisition company co-led by George Mattson, who previously led Goldman’s global industrial group, and former PerkinElmer Chairman and CEO Gregory Sum.

Sky News first covered the talks on Saturday and said a deal will be announced in the coming weeks. Virgin Orbit declined CNBC’s request for comment.

The company is a spin-off from Branson’s space tourism company Virgin Galactic. Virgin Orbit is privately owned by Branson’s multinational conglomerate Virgin Group, with a minority stake in Abu Dhabi sovereign wealth fund Mubadala.

The company’s first demonstration launch in May 2020.

Greg Robinson | Jungfrau Railway Or

Virgin Orbit uses a modified Boeing 747 aircraft to launch its missiles, a method known as air launch. Rather than launching missiles from the ground like competitors like Rocket Lab or Astra do, the company’s planes carry its LauncherOne missiles up to an altitude of around 45,000 feet and drop them just before they fire the engine and accelerate into space – a method that the company is promoting more flexibly than a ground-based system.

LauncherOne is designed to carry small satellites weighing up to 500 kilograms, or around 1,100 pounds, into space. Virgin Orbit completed its first successful launch in January and plans to have its second later this month.

Next Gen II raised $ 350 million when it completed its IPO in March and an additional $ 33 million greenshoe deal in April for a total of $ 383 million. The funds would primarily be used to help Virgin Orbit scale its business. Virgin Orbit CEO Dan Hart told CNBC in October that the company plans to raise approximately $ 150 million in fresh capital.

Branson brought Virgin Galactic to the public in 2019 through a SPAC deal with billionaire investor Chamath Palihapitiya.

Become a smarter investor with CNBC Pro.
Get stock picks, analyst calls, exclusive interviews and access to CNBC TV.
Sign in to one. to start Try it for free today.

Categories
Business

Public well being prof on Taiwan outbreak, vaccination progress

The recent Covid-19 outbreak in Taiwan is a lesson that a containment strategy that targets zero local transmission may not be sustainable in the long term, a public health professor said Tuesday.

Before the recent explosion in cases, Taiwan had reported very few Covid infections for over a year – and most were imported. This allowed daily activities to continue largely normally and the island received international praise for its containment measures.

But it made Taiwan “completely vulnerable” to new variants of the coronavirus that are more communicable and potentially more serious, said Benjamin Cowling, professor and head of the epidemiology and biostatistics department at the University of Hong Kong’s School of Public Health.

“Probably less than 1% of their population have a natural infection, and therefore natural immunity, and … less than 1% have been vaccinated – so they are almost entirely susceptible,” Cowling told CNBC’s Squawk Box Asia.

Taiwan, with a population of around 24 million, has reported more than 8,500 confirmed Covid cases and 124 deaths as of Monday, official data showed.

It is a warning to other parts of Asia that this strategy of elimination is also trying, it is not necessarily sustainable in the long run.

Benjamin Cowling

Hong Kong University School of Public Health

Cowling said Taiwan will have a hard time controlling the recent outbreak. Authorities may need tougher social distancing measures as testing capacity hasn’t been ramped up enough and the island’s vaccination progress has been slow, he added.

“It is a warning to other parts of Asia that are also trying this elimination strategy, it is not necessarily sustainable in the long term,” said the professor.

Asian economies have generally shown lower tolerance to Covid infection compared to their competitors in other regions.

Governments in Hong Kong and Singapore, for example, have been quick to tighten measures to curb small upward movements in cases. Meanwhile, countries like the US and UK are still reporting thousands of cases every day, but faster vaccination has allowed countries to lift restrictions.

Like many of its regional competitors in Asia, Taiwan faced challenges in securing Covid vaccines, Cowling said. Part of Taiwan’s hurdle is politics, the professor said.

Taiwan President Tsai Ing-wen said in a Facebook post last week that the government had bought vaccines developed by AstraZeneca and Moderna. She accused China Blocking of a deal with Germany’s BioNTech, which has developed a vaccine together with US pharmaceutical company Pfizer.

Beijing rejects Tsai’s allegations.

China claims Taiwan as a runaway province that will one day have to be reunited with the mainland – if necessary by force. The Chinese Communist Party has never ruled Taiwan, which is a democratic, self-governing island.

“There are a lot of policies out there when it comes to getting vaccines into Taiwan,” Cowling said. “I think they will do it, but right now they won’t be able to vaccinate enough people to stop the current outbreak. They have to use social distancing and bans to deal with it.”

Categories
Health

CDC masks pointers may improve threat of spreading Covid at work and in public, scientists say

People without a mask are walking in Times Square in New York City on May 19, 2021.

John Smith | VIEW press | Corbis News | Getty Images

The CDC’s new mask guidelines could actually increase the risk of Covid-19 spreading in public spaces and workplaces, scientists from a leading group of infectious diseases said Thursday.

The Centers for Disease Control and Prevention abruptly reversed their mask guidelines for vaccinated Americans last week to say that vaccinated people will no longer need to wear a mask indoors or outdoors in most settings. Officials said they changed their guidelines in part because research shows the vaccines offer very high levels of protection against the disease of Covid-19 and spread it to others.

“There is no debate about this fact,” said Dr. Jeffrey Duchin, who sits on the CDC’s Advisory Committee on Immunization Practices, at a news conference hosted Thursday by the Infectious Diseases Society of America. However, the agency’s announcement created widespread confusion and frustration because “it was unexpected and lacked the necessary context for implementation by the state and local health community,” he said.

Duchin is the society’s liaison with the CDC’s Vaccination Committee. The company represents leading specialists in infectious diseases in the USA

“There was no information on how the guidelines could be used in practice, particularly in relation to the inability to check vaccination status,” said Duchin. The CDC also did not provide guidance on whether people should continue to wear masks in areas with high transmission rates or low vaccination rates, he said. “What the CDC did, however, was not optimal and gave the wrong impression that the mask mandates were being lifted.”

Doctors across the country and federal health officials continue to stress that only vaccinated people are safe to remove their masks. The new mask management was misinterpreted as the end of the pandemic and mask mandates, which puts the local health authorities in a very difficult position. States in the United States took the news as a cue to facilitate mask mandates. Texas Governor Greg Abbott used the new guidance to justify signing an executive order that threatens the fine for local officials and communities for not dropping mask requirements.

Duchin said that both vaccinated and unvaccinated people are likely safe outdoors without masks, but they are not indoors.

“Now the risk of Covid-19 spreading in crowded indoor spaces with unvaccinated people and especially with poor ventilation is increased,” said Duchin. While the CDC’s scientific basis for the change is “solid,” Duchin said ending the mandate for inner masks “could lead to increased risk in public spaces and workplaces with avoidable spread of Covid-19, mostly among the unvaccinated spreads. “

Vaccination rates vary across the country, and the majority of those vaccinated are older adults. Large subgroups such as younger adults remain unvaccinated.

Dr. Jeanne Marrazzo, who also spoke at the briefing, said research has shown that up to 3% of Americans have been told by their doctors that they have some level of immunodeficiency, which puts them at an increased risk of being exposed to Covid be.

“Millions of people fit that bill, and we literally have very little data on whether the vaccine works in them,” Marrazzo said. “There is a real reason to be careful and interpret the guidelines carefully.”

The scientists also said people need to acknowledge that there is uncertainty about the future course of the pandemic, the effects of emerging variants, the duration of immunity, and the potential for a Covid-19 resurgence.

“The Covid-19 outbreak is by no means over, there is still significant uncertainty and there is still significant disease activity,” said Duchin.

If someone is fully vaccinated and doesn’t have other conditions that threaten their community, and if the rate of Covid where they live is relatively low and the vaccination rate is high, Marrazzo said it would be “100% okay, pretty much anywhere without one. ” Mask.”

Marrazzo added that despite being fully vaccinated, she will continue to wear a mask around the house as vaccination rates in her community are not even 50%.

“If I knew we were seeing really notable decreases in hospital stays and symptomatic illnesses that may be related to Covid and that have a very high vaccination rate, I would probably go without a mask, but I won’t see this anytime soon,” she said.

While nearly half of all people in the United States, 160.2 million, received at least one shot, Marrazzo said only 4.6% of the world’s population did the same.

“People need to be aware of what’s going on and watch out for vaccination rates, look for the involvement of these new varieties and think about being ready to get things going again,” warned Marrazzo.

Correction: This story has been updated to reflect that the press conference was hosted by the Infectious Diseases Society of America.

Categories
Health

India Covid disaster exhibits public well being neglect, issues, underinvestment

A family waits in an ambulance with a patient who tests positive for COVID-19 to be admitted to hospital in Kolkata, India on May 10, 2021.

Debarchan Chatterjee | NurPhoto | Getty Images

World attention is now turning to India, the epicenter of the global pandemic, as the country battles a deadly second wave of Covid-19.

The unfolding human tragedy has exposed the deeply ingrained problems of the Indian health system after decades of neglect and underinvestment.

The crisis has brought India’s public health system to its knees. Scenes of hospitals running out of beds and people desperate for life-saving oxygen or critical medical care for their loved ones have made international headlines.

Low health care allocations

Since its independence in 1947, health has not been seen as an economically productive expense in the country for a long time – as opposed to investing in industry, agriculture and service sectors, K Srinath Reddy, president of the Public Health Foundation of India, told CNBC.

“For several decades, India’s health systems have not received the respect and resources they deserve. Public health funding has stagnated at around 1% of GDP and out-of-pocket health spending has been over 60% even in recent years” he said in an email. “The central government, as well as most of the state governments, had low budget allocations for health.”

India’s health spending is comparatively much lower than in many other countries.

The US spent almost 17% of its gross domestic product on public health care in 2018, while France and Germany spent more than 11% of GDP this year, according to the World Bank.

In a comparison of India with the other BRICS countries – Brazil, Russia, India, China and South Africa – India spent the least on health care in 2018. Brazil spent 9.5% of its GDP on health care that year, South Africa spent 8.1%, Russia 5.3% and China spent 5.35%.

India is now the second worst infected country in the world, just behind the United States.

The South Asian nation has reported more than 300,000 new infections per day in the past few weeks. According to the Ministry of Health, cumulative Covid infections reached almost 24.7 million on Sunday with more than 270,284 deaths.

However, health experts warn that the numbers are likely to be grossly underreported and the true extent of Covid infections and the number of people may never be officially known.

In a recent report by Fitch Solutions, the research firm said that despite several health reforms, India remains ill-positioned to tackle the rapid spread of the pandemic.

“With 8.5 hospital beds per 10,000 inhabitants and 8 doctors per 10,000, the country’s health sector is not prepared for such a crisis. Furthermore, the significant inefficiency, dysfunction and acute shortages of health systems in the public sector do not exist to meet the growing needs of the population “added the report.

The numbers are grim for a country like India with 1.4 billion people, which makes up 18% of the world’s population.

Lack of political will

India’s second wave started around February and accelerated through March and April. The virus spread quickly due to complacency with wearing masks at religious festivals and political rallies that drew large crowds in different parts of the country.

While the pandemic has highlighted the structural weaknesses of India’s public health system, those issues have always been there, Chandrakant Lahariya said. a Expert in medical public policy and health systems based in New Delhi.

I believe that after the long and excruciating pandemic, the political will is now stronger.

Chandrakant Lahariya

Expert in medical public order and health systems

He said this was mainly due to a lack of political will from successive political parties and the government, which had the power not to make public health a priority.

“Public health has never been a political priority or an election agenda,” he said. “Through the hands-off approach, the government has been sending a kind of message that health is an individual responsibility. People are unaware that elected governments and political leaders should be accountable and accountable to ensuring health services.”

This is where the problem arises, noted Lahariya.

“It has allowed the private health sector to grow by leaps and bounds while the public sector remains underfunded and underperforming,” he said in an email. “Now we are in this situation.”

Few Indians have health insurance

India’s private hospitals are largely commercialized and for-profit, and focus on treating disease. What makes matters worse is that the majority of Indians do not have health insurance and pay for health care out of their own pocket.

According to the Fitch report, more than 80% of the Indian population still has no significant health insurance coverage and around 68% have limited or no access to essential medicines.

While a pandemic can overwhelm almost any health system, including the best-equipped, the current situation in India was not inevitable, noted Vageesh Jain, a trained public health doctor in the UK

“The fundamental problem remains that the commercially operated private hospital system does not aim to provide long-term care to people to prevent and control disease,” said Jain, who is currently working with Public Health England on health protection in response to Covid-19.

Given the complex and multi-agency solutions, it is difficult to address such issues in any context, he added.

“But it is especially difficult in India, where there may be other quick public policy wins that are more deserving of immediate attention,” he argued.

A wake-up call for India?

India’s Prime Minister Narendra Modi has been widely criticized for failing to act earlier to suppress the virus resurgence.

In a rare reprimand, the British medical journal The Lancet recently beat up the Modi government for squandering early successes in controlling Covid and “presiding over a self-inflicted national disaster”.

“I believe that the political will is now stronger after the long and excruciating pandemic,” said Reddy of the Public Health Foundation of India. He added that the latest central budget and the Finance Commission’s recommendations are positive indicators.

The devastating situation caused by the ongoing wave is likely to be forgotten. But it must not be forgotten.

When the budget was announced in February, Indian Finance Minister Nirmala Sitharaman proposed that spending on health and wellbeing in India should more than double to $ 30.1 billion (rupees 2.2 trillion).

This includes strengthening national institutions and creating new institutions to identify and cure new diseases. There is also a new federal system in place to develop the country’s capacity for primary, secondary and tertiary care.

However, whether the crippling crisis will be a wake-up call for India to take its public health seriously remains to be seen, experts say.

“With this ongoing pandemic, the memories of the public and policymakers will last stronger and longer. Even after the pandemic has ended, it is a constant reminder that if We don’t invest, the economy will continue to slide on the banana peels of public health failure in public health and in strong health systems, “Reddy said.

Lahariya added that India has seen many public health disasters and emergencies. But most have resulted in very little, if any, changes in health systems.

“The time has come for India to have solid accountability of citizens to elected leaders. Questions should be asked of the people who elect them. Then only we can expect change,” he said.

“The devastating situation caused by the ongoing wave is likely to be forgotten. But it should not be forgotten.”

Categories
Health

A whole bunch of Epidemiologists Anticipated Masks-Sporting in Public for at Least a 12 months

When federal health officials said Thursday that fully vaccinated Americans would no longer have to wear masks in most locations, it came as a surprise to many in the public health sector. It was also in stark contrast to the views of a large majority of epidemiologists surveyed by the New York Times over the past two weeks.

In the informal poll, 80 percent said Americans were required to wear masks in indoor public spaces for at least another year. Only 5 percent said that people will no longer have to wear masks indoors by summer.

In large outdoor crowds, such as at a concert or protest, 88 percent of epidemiologists said it was necessary even for fully vaccinated people to wear masks.

“Unless vaccination rates rise to 80 or 90 percent in the next few months, we should wear masks in large indoor public spaces,” said Vivian Towe, program director at the Institute for Patient-Centered Results.

Responses came from 723 epidemiologists submitted between April 28 and May 10 before the Centers’ new guidelines for Disease Control and Prevention. The survey asked epidemiologists if they were in different sized groups outdoors and indoors with people whose vaccination status was unknown. The situations were in line with the new guidelines governing behavior in public places regardless of their size, where it is impossible to know the vaccination status of others.

Federal health officials have already said vaccinated people can be inside with other vaccinated people, and epidemiologists have largely agreed. However, the CDC’s new guidelines state that masks are no longer required for fully vaccinated individuals, regardless of the size of the congregation and whether they are indoors or outdoors, except in certain situations, such as in a doctor’s office or on public transit.

Epidemiologists are broadly very cautious about Covid-19 as they are trained to understand risks and prevent the spread of infectious diseases. Nearly three-quarters identified themselves as risk averse, and unlike many Americans, they’ve likely been able to work from home over the past year. But they are also trained as many of the academics at the CDC who developed the new policy, and about a third of those surveyed work in government, mostly at the state level.

They admitted that many Americans no longer want to wear masks – and that many have already stopped.

Wearing masks “will be a necessity, which is a very different question from the duration,” said Sophia K., epidemiologist at the Great Lakes Inter-Tribal Council. “I assume that most people will refuse to wear masks in public by the end of 2021, regardless of whether there is still a pandemic or not.”

Many epidemiologists echoed the CDC by saying that people who were fully vaccinated could congregate without taking precautions. However, the CDC went even further than the epidemiologists by giving vaccinated individuals OK to end masking in groups with an unknown number of unvaccinated individuals.

Updated

May 14, 2021, 11:24 a.m. ET

“Either you trust the vaccine or you don’t,” said Kristin Harrington, Ph.D. Student at Emory. “And if we trust the vaccine, it means that there is no limit to the number of people who can get vaccinated.”

Others recognized that political decisions are based on many goals, such as stimulating the economy and encouraging people to get vaccinated.

Most said, however, that wearing masks was still necessary for the time being as the number of Americans vaccinated has not yet reached a level that scientists believe is necessary to significantly slow the spread of the virus. By then, there are too many chances that vaccines that aren’t 100 percent effective will fail, they said.

“Crowded indoor and outdoor conditions require a mask until the community in Covid is much lower,” said Luther-King Fasehun, a doctor and doctor of epidemiology. Student at Temple University.

Sally Picciotto, an epidemiologist at the University of California at Berkeley, said the decision to stop wearing masks indoors was dependent on more people rolling up their sleeves to get the shot.

Respondents also said masks are important in protecting people at high risk and those who cannot be vaccinated, such as children or people with underlying health conditions, while the virus is still spreading.

“Until community transmission is lower, wearing masks will protect the entire community and the rest of the people in the room,” said Julia Raifman, an assistant including children, immunocompromised individuals, and Black and Latino communities affected by Covid- 19 more badly hit were professor of public health at Boston University.

A quarter of epidemiologists in the survey said that people would need to continue wearing masks indefinitely in certain settings, and some said they wanted to continue wearing them in places like airplanes or concert halls, or during the winter virus season.

“Heck, I can now wear a mask for any flu season,” said Allison Stewart, the senior epidemiologist for Williamson County and the Cities Health District in Texas. “Sure, it was nice not to have been sick for over a year.”

Alana Cilwick, epidemiologist for the Colorado Department of Public Health, said, “I plan to wear a mask indoors for the foreseeable future as the vaccine delay is great, especially in higher risk environments like the gym or on an airplane. ”

Only a fifth of epidemiologists said it was safe for fully vaccinated people to socialize indoors without masks in a group of unlimited size. A majority said that indoor gatherings should be limited to five or fewer households.

Even outside, where the coronavirus is spreading much less often, almost all epidemiologists said it was necessary to keep wearing masks en masse when people are around others whose vaccination status they do not know.

“Masks are the second most important vaccine prevention strategy,” said Professor Raifman.

Categories
Business

Inside Astra’s rocket manufacturing facility, as the corporate prepares to go public

Astra VP of Manufacturing Bryson Gentile (left) and CEO Chris Kemp remove a protective cover from a missile fairing half.

Michael Sheetz | CNBC

ALAMEDA, Calif. – Astra missile maker wants to simplify the launch business. The soon-to-be-listed company aims to both reduce manufacturing costs and drastically increase the number of starts on a daily rate.

Astra is preparing to go public by the end of June through a merger with SPAC Holicity, which will bring up to $ 500 million in capital to the company. Meanwhile, Astra is expanding its headquarters in San Francisco Bay as the company prepares for its next launch this summer.

A SPAC, or special purpose vehicle, acquires capital from an IPO and uses the proceeds to buy a private company and bring it public.

CNBC toured Astra’s growing facility earlier this month, which was attended by Chairman and CEO Chris Kemp and Vice President of Manufacturing Bryson Gentile.

Benjamin Lyon, Executive Vice President of Engineering, as well as Senior Vice President of Factory Engineering Pablo Gonzalez and Vice President of Communications Kati Dahm also attended.

The company’s management comes from a variety of backgrounds in space and technology: Kemp from NASA and cloud software provider OpenStack, and Gentile from SpaceX. Meanwhile, Lyon came from Apple, Gonzalez from Tesla and Dahm from the electric vehicle manufacturer NIO.

An overview of the location of the Astra headquarters on San Francisco Bay in Alameda, California.

Google Maps

The Astra facility uses the infrastructure left over from the former Air Station Alameda of the US Navy. The company initially started with around 30,000 square meters. It now spans around 250,000 square feet – including all the way to the edge of the bay, where a newly built city ferry terminal connects Alameda with the 10-minute drive from downtown San Francisco.

The main area of ​​the company’s headquarters, approximately 25% of its floor space, provides open space for much of its missile development and assembly.

Astra has also put all of its equipment on wheels, with management emphasizing the flexibility it wants to maintain in expanding its manufacturing capabilities.

The production floor of the Astra headquarters in Alameda, California.

Michael Sheetz | CNBC

The short-term goal is to reach orbit, the next hurdle after the last launch that broke the barrier to space in December. The next launch of Astra is planned for this summer, which will also be the first to generate revenue for the company.

Astra’s rocket is 40 feet high and can launch up to 100 kilograms into orbit. This makes it part of the small rocket category currently led by Rocket Lab.

However, Astra is focused on keeping the price of the rocket as low as possible. It’s priced at just $ 2.5 million per launch versus Rocket Labs Electron’s roughly $ 7 million per launch.

A closer look at half an Astra missile nose cone, also known as a fairing.

Michael Sheetz | CNBC

The company emphasized the cost-cutting methods implemented in its approach, with Astra believing that it is possible to achieve a production rate of one rocket per day within a few years. The company’s employees compare their rocket to building a small Cessna airplane.

An example of Astra demonstrating during the tour how to build fairings – the nose cone of the rocket that protects the satellites during launch.

The company said the first cladding was made of composite carbon fiber, which is typical in the aerospace industry because the material is light and stiff. However, the carbon fiber fairing cost $ 250,000, which required a different solution as the company ultimately wants to bring the total cost of its rocket down to less than $ 500,000.

Astra decided to build its second metal fairing, which cost about $ 130,000. However, the company had to go further.

Vice President Gentile explained how the company is now using aluminum tubing to give the cladding its strength, combining that with a dozen petals, which are thin, curved pieces of metal. That reduces the cost of the fairings to $ 33,000.

Astra plans to get under $ 10,000 per disguise by stamping them instead of riveting them together.

Members of the Astra management team gathered from the right around a rocket in production: Vice President of Production Bryson Gentile, SVP of the factory engineer Dr. Pablo Gonzalez, Vice President of Communication Kati Dahm, Founder and CEO Chris Kemp, EPP of the engineer Benjamin Lyon.

Michael Sheetz | CNBC

Another long-term hurdle for the company will be to work with regulators to get licenses for launches quickly if it is able to hit a daily rate. Astra’s leadership said they are working very closely with the Federal Aviation Administration to streamline the licensing process, noting that they want a dozen or more spaceports around the world.

Astras Mission Control Center for launches.

Michael Sheetz | CNBC

Astra is also optimizing the operational aspect of its launches, reducing the number of people in its mission control to less than 10 and requiring only six people to set up the missile at the physical launch site.

The aim is to reduce the number of people in mission control to just two, effectively a pilot and a co-pilot, by automating most of the processes.

Astra’s outdoor workstation, where pieces of missile ground support equipment are assembled and prepared for launch.

Michael Sheetz | CNBC

The missile system, including the strong back that lifts the vehicle vertically for a launch, is packed in a few shipping containers.

First, Astra rolls a strong back out of the container and into the factory. Then an overhead crane drops the missile directly onto the strongback. Finally, the entire system is rolled into a container and then shipped.

Astra has three strong backs in assembly, more will follow.

The thick doors that led to one of Astra’s rocket engine test facilities, which was previously a US Navy engine test facility.

Michael Sheetz | CNBC

The former marine facility also has two engine test areas with thick reinforced concrete walls.

The night before the CNBC tour, Astra conducted tests on the top tier of a missile. This made the engine bay a cool place thanks to the sub-zero temperatures of a liquid oxygen tank.

In an Astra test bunker where Senior Manager Andrew Pratt shows a pair of fuel tanks connected to a missile that was tested the night before.

Michael Sheetz | CNBC

During a hot fire test, the interior of the chambers reaches 1,200 degrees Fahrenheit when one of Astra’s Dolphin rocket engines is ignited. Astra officials said the company can run up to 10 to 15 first stage tests of a missile in a day, or more than 30 upper stage tests in a day.

Review of the exhaust tunnel of the test bay from Astra.

Michael Sheetz | CNBC

Astra will continue to expand its current presence in Alameda, including a lease for a 500-foot pier and plans for an ocean launch platform that can be loaded with a rocket in the bay.

The view behind Asta’s headquarters in Alameda, California overlooking the San Francisco Bay.

Michael Sheetz | CNBC

Chris Kemp, CEO of Astra, shows part of the space the company plans to use to expand its headquarters.

Michael Sheetz | CNBC

Categories
Health

Public demand for AstraZeneca vaccine falls after blood clot scares

A medical worker fills a syringe with AstraZeneca vaccine at Santa Caterina da Siena – Amendola secondary school in Salerno on March 13, 2021 in Salerno, Italy.

Francesco Pecoraro | Getty Images News | Getty Images

LONDON – Public preference for the coronavirus vaccine developed by AstraZeneca and the University of Oxford has fallen since reports surfaced suggesting it may be linked to some cases of unusual blood clotting events.

An April study of nearly 5,000 adults in the UK, with Covid vaccine uptake high and the vaccination program well established, found that public preference for the AstraZeneca Covid vaccine has declined since March and there is a belief that that he caused blood clots to have increased.

The UK academic study found that 17% of the public now say they would prefer the AstraZeneca vaccine if given a choice – up from 24% towards the end of March.

And 23% of people now believe the AstraZeneca vaccine causes blood clots – up from 13% in March. However, the public are still the most likely to say that this claim is false (39%) or that they don’t know if it is true (38%).

The study, conducted April 1–16 by the University of Bristol, King’s College London, and the NIHR Health Protection Unit for Emergency Preparedness and Relief, found a “big difference” in beliefs before and after MHRA ( the UK Medicines Agency) announced on April 7th that there is a possible link between the vaccine and extremely rare blood clots.

The study found that 17% of respondents in the first week of this month thought this claim was true, compared with 31% who were asked about it.

Why autumn

Since the first clinical data was published, the vaccine has shown an average effectiveness rate of 70% (subsequent studies in the US have shown an effectiveness rate of 79%, and other studies have shown that the effectiveness rate increases with a larger gap between the first and second doses ) The fate of the AstraZeneca vaccine is mixed to say the least.

Continue reading: Dates, Doubts, and Disputes: A Timeline for AstraZeneca’s Covid Vaccine Problems

One of the recent hurdles for the AstraZeneca vaccine was a small number of reports of unusual, sometimes fatal, blood coagulation events that occurred in post-vaccinating people in Europe in February, causing several countries to suspend use of the vaccine.

The UK and EU drug regulators (the UK Medicines and Health Products Regulatory Authority and the European Medicines Agency) examined the reports and said that while there is a possible link between the vaccine and low incidence of blood clotting, the benefits of the vaccine are significant outweighing them Risks.

The Anglo-Swedish vaccine maker, British government and experts largely defended the vaccine, saying it protected millions of people by reducing Covid cases, hospitalizations and deaths.

In addition, experts tried to correlate the risk, saying the number of reported rare blood clotting cases with low platelets was about one case in 250,000 people vaccinated and one death in one million.

Britain is fortunate that it has traditionally received high levels of public support for vaccination. The vaccine preference survey found that, despite the growing belief that it was associated with blood clots, the AstraZeneca vaccine did not affect general confidence in vaccines in general. 81% say vaccines are safe, compared to 73% who said so in late 2020.

Similarly, views on how well vaccines work have changed: 86% say they are effective, up from 79% in November and December 2020.

However, surveys have shown that the public perception of the AstraZeneca vaccine has deteriorated in mainland Europe, and there is scattered evidence that people in the EU are using the AstraZeneca vaccine (referred to as the “Aldi” vaccine after the low-cost food chain will) because in favor of the coronavirus vaccine from Pfizer-BioNTech, which also prevails when EU vaccinations are introduced.

Continue reading: “The damage is done”: Europe’s caution against the AstraZeneca vaccine could have far-reaching consequences

Moderna’s shot and Johnson & Johnson’s shot have also been approved for use in the EU and the UK, but have been less widely used, EU vaccination data show.

Hesitation to vaccinate can apparently work both ways. A British doctor reported in the Evening Standard newspaper in January that some of his patients had turned down the opportunity to receive the Pfizer vaccine, saying they would “wait for the English one.”

Categories
Politics

Supreme Courtroom takes up main weapons case over proper to hold in public

Media representatives have settled in front of the US Supreme Court building in Washington.

Al Drago | Reuters

The Supreme Court on Monday agreed to hear a major dispute over the second amendment that could determine whether the constitution protects a right to publicly carry arms.

The decision, announced in a resolution, comes after President Joe Biden faces pressure from activists to take action to limit the availability of high-powered weapons amid outcry over mass shootings.

Proponents of increased arms control measures have raised concerns that the country’s highest court, which has a 6-3 majority of Republican candidates, could expand the scope of the second amendment.

The Supreme Court previously ruled that the second amendment protects the individual’s right to carry a weapon in the home for self-defense. Last year it declined to make a substantial decision on its first major case of the second amendment in a decade.

In the case where the court has agreed to hear the New York State Rifle & Pistol Association against Keith Corlett, # 20-843, on Monday, individuals and a state organization are contesting a New York law under which individuals ” Correct Reasons “must be provided in order to obtain authorization to carry a pistol in the open.

Robert Nash and Brendan Koch, the people who brought the suit, both applied for licenses to carry handguns for self-defense and were refused. A district court found that neither man had any reasonable cause for neither facing “special or unique danger” [their] Life.”

A federal appeals court upheld the lower court’s decision not to license the men.

In their appeal, written by former Attorney General Paul Clement, the men argued that New York law was under the precedents of the District of Columbia Supreme Court against Heller ruled in 2008 and McDonald v City of Chicago ruled in 2010 was unconstitutional.

“As this court made clear in both Heller and McDonald’s, the second amendment essentially guarantees the right to keep and carry weapons for self-defense,” wrote Clement. “Like the threats a need for self-defense might create, this individual and fundamental right necessarily extends beyond the four walls of one’s home.”

New York attorney general Letitia James wrote a brief letter to the judges not to admit the case that the New York law was compatible with the Heller and McDonald rulings of the Supreme Court. In McDonald’s, the court wrote that its opinion was not intended to lift certain “long-standing bans” on the use of weapons.

James wrote that New York law has existed in the same essential form since 1913 and “is backed by a centuries-old tradition of state and local measures regulating the public transport of firearms”.

She also wrote, “New York law directly promotes the overriding interests of the state to protect the public from gun violence.”

A decision is expected by summer 2022.

CNBC policy

Read more about CNBC’s political coverage:

This is the latest news. Check for updates again.